Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 06, 2022 at 05:08 pm EDT
Skye Bioscience, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 3.04 million compared to USD 2.16 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.